LH Labcorp
Q3 2025 10-Q
Labcorp (LH) 10-Q quarterly report for Q3 2025, filed with SEC EDGAR on Oct 31, 2025 for the fiscal period ending Sep 30, 2025. This page provides AI-powered analysis including management discussion & analysis (MD&A), risk factor updates, and key quarterly financial data such as revenue and net income extracted from XBRL.
AI Filing AnalysisQ3 2025 10-Q
Management Discussion & Analysis
- • Revenue $3.56B Q3 FY25, up 8.6% YoY from $3.28B; organic growth 6.2%, acquisitions 1.7%, currency 0.7%
- • Operating margin Q3 FY25: Dx 16.3% vs 15.2% YoY, BLS 16.5% vs 16.4% YoY; total operating income $396.6M up 56.1% YoY
Risk Factors
- • No material changes in risk factors from 2024 10-K carried forward
- • Pandemic impact risk persists with potential lab test volume fluctuations
Quarterly Financial SummaryXBRL
Revenue
$3.6B
▲ +8.6% YoY▲ +1.0% QoQ
Net Income
$261M
▲ +54.2% YoY▲ +9.8% QoQ
Gross Margin
28.8%
▲ +121bp YoY▼ -89bp QoQ
Operating Margin
11.1%
▲ +339bp YoY▼ -5bp QoQ
Net Margin
7.3%
▲ +217bp YoY▲ +58bp QoQ
ROE
3.0%
Total Assets
$18.3B
EPS (Diluted)
$3.12
▲ +56.0% YoY▲ +9.9% QoQ
Operating Cash Flow
$387M
▲ +39.6% YoY▼ -37.6% QoQ
Source: XBRL data from Labcorp Q3 2025 10-Q filing on SEC EDGAR. All figures in USD.
Get deeper insights on Labcorp
Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.